Spellman, S, Setterholm, M, Maiers, M, Noreen, H, Oudshoorn, M, Fernandez-Viña, M et al. Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry. Biol Blood Marrow Transplant. 2008;14(9 Suppl):37–44. doi: 10.1016/j.bbmt.2008.05.001. Epub 2008 Jun 20 (Review).Google Scholar

Spellman, SR, Eapen, M, Logan, BR, Mueller, C, Rubinstein, P, Setterholm, MI et al.; National Marrow Donor Program; Center for International Blood and Marrow Transplant Research. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood. 2012;120(2):259–65. doi: 10.1182/blood-2012-03-379032. Epub 2012 May 17.CrossRefGoogle ScholarPubMed

Nunes, E, Heslop, H, Fernandez-Vina, M, Taves, C, Wagenknecht, DR, Eisenbrey, AB et al. Definitions of histocompatibility typing terms. Blood. 2011;118(23):e180–3. doi:10.1182/blood-2011-05-353490. Epub 2011 Oct 14.CrossRefGoogle ScholarPubMed

Howard, CA, Fernandez-Vina, MA, Appelbaum, FR, Confer, DL, Devine, SM, Horowitz, MM et al. Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant. 2015;21(1):4–7. doi: 10.1016/j.bbmt.2014.09.017. Epub 2014 Sep 30.CrossRefGoogle ScholarPubMed

Pidala, J, Lee, SJ, Ahn, KW, Spellman, S, Wang, HL, Aljurf, M et al. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood. 2014;124(16):2596–606. doi: 10.1182/blood-2014-05-576041. Epub 2014 Aug 26.CrossRefGoogle ScholarPubMed

Lee, SJ, Klein, J, Haagenson, M, Baxter-Lowe, LA, Confer, DL, Eapen, M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13):4576–83. Epub 2007 Sep 4.Google Scholar

Verneris, MR, Lee, SJ, Ahn, KW, Wang, HL, Battiwalla, M, Inamoto, Y et al. HLA mismatch is associated with worse outcomes after unrelated donor reduced-intensity conditioning hematopoietic cell transplantation: an analysis from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2015 Jun 6. pii: S1083-8791(15)00389–4. doi: 10.1016/j.bbmt.2015.05.028 Epub ahead of print.Google Scholar

Fürst, D, Müller, C, Vucinic, V, Bunjes, D, Herr, W, Gramatzki, M et al. High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. Blood. 2013;122(18):3220–9. doi: 10.1182/blood-2013-02-482547. Epub 2013 Sep 17. [Erratum in: Blood. 2014 Mar 13;123(11):1768.]Google Scholar

Spellman, S, Bray, R, Rosen-Bronson, S, Haagenson, M, Klein, J, Flesch, S et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood. 2010;115(13):2704–8. doi:10.1182/blood-2009-09-244525. Epub 2010 Jan 20.Google Scholar

Ciurea, SO, Thall, PF, Wang, X, Wang, SA, Hu, Y, Cano, P et al. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood. 2011;118(22):5957–64. doi: 10.1182/blood-2011-06-362111. Epub 2011 Oct 3.CrossRefGoogle ScholarPubMed

Gragert, L, Eapen, M, Williams, E, Freeman, J, Spellman, S, Baitty, R et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med. 2014;371(4):339–48. doi: 10.1056/NEJMsa1311707.CrossRefGoogle ScholarPubMed

Wade, JA, Hurley, CK, Takemoto, SK, Thompson, J, Davies, SM, Fuller, TC et al. HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. Blood. 2007;109(9):4064–70. Epub 2007 Jan 3.Google Scholar

Duquesnoy, RJ, Takemoto, S, de Lange, P, Doxiadis, II, Schreuder, GM, Persijn, GG et al. HLA matchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation. 2003;75(6):884–9.Google Scholar

Duquesnoy, R, Spellman, S, Haagenson, M, Wang, T, Horowitz, MM, Oudshoorn, M. HLA matchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors. Biol Blood Marrow Transplant. 2008;14(9):1064–71. doi: 10.1016/j.bbmt.2008.07.001.CrossRefGoogle ScholarPubMed

Elsner, H, Blasczyk, R. Sequence similarity matching: proposal of a structure-based rating system for bone marrow transplantation. Eur J Immunogenet. 2002;29:229–36.Google Scholar

Risler, JL, Delorme, MO, Delacroix, H, Henaut, A. Amino acid substitutions in structurally related proteins: A pattern recognition approach. Determination of a new and efficient scoring matrix. J Mol Biol. 1988; 204(4):1019–29.Google Scholar

Shaw, BE, Barber, LD, Madrigal, JA, Cleaver, S, Marsh, SG. Scoring for HLA matching? A clinical test of HistoCheck. Bone Marrow Transplant. 2004; 34(4):367–8.CrossRefGoogle ScholarPubMed

Askar, M, Sobecks, R, Morishima, Y, Kawase, T, Nowacki, A, Makishima, H et al. Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17(9):1409–15.CrossRefGoogle ScholarPubMed

Spellman, S, Klein, J, Haagenson, M, Askar, M, Baxter-Lowe, LA, He, J et al. Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18(5):739–46. doi: 10.1016/j.bbmt.2011.09.008. Epub 2011 Sep 29.CrossRefGoogle Scholar

Ferrara, GB, Bacigalupo, A, Lamparelli, T, Lanino, E, Delfino, L, Morabito, A et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with subsitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood. 2001; 98(10):3150–5.CrossRefGoogle Scholar

Pidala, J, Wang, T, Haagenson, M, Spellman, SR, Askar, M, Battiwalla, M et al. Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. Blood. 2013;122(22):3651–8. doi: 10.1182/blood-2013-05-501510. Epub 2013 Aug 27.CrossRefGoogle Scholar

Kawase, T, Morishima, Y, Matsuo, K, Kashiwase, K, Inoko, H, Saji, H et al.; Japan Marrow Donor Program. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood. 2007;110(7):2235–41. Epub 2007 Jun 6.Google Scholar

Kawase, T, Matsuo, K, Kashiwase, K, Inoko, H, Saji, H, Ogawa, S et al.; Japan Marrow Donor Program. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood. 2009;113(12):2851–8. doi: 10.1182/blood-2008-08-171934. Epub 2008 Nov 7.CrossRefGoogle ScholarPubMed

Marino, SR, Lin, S, Maiers, M, Haagenson, M, Spellman, S, Klein, JP et al. Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation. Bone Marrow Transplant. 2012;47(2):217–26. doi: 10.1038/bmt.2011.56. Epub 2011 Mar 28.Google Scholar

Hurley, CK, Woolfrey, A, Wang, T, Haagenson, M, Umejiego, J, Aljurf, M et al. The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors. Blood. 2013;121(23):4800–6. doi: 10.1182/blood-2013-01-480343. Epub 2013 May 1.CrossRefGoogle ScholarPubMed

Kanda, J, Ichinohe, T, Fuji, S, Maeda, Y, Ohashi, K, Fukuda, T et al.; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2015;21(2):305–11. doi: 10.1016/j.bbmt.2014.10.015. Epub 2014 Oct 18.CrossRefGoogle Scholar

Thomas, R, Thio, CL, Apps, R, Qi, Y, Gao, X, Marti, D et al. A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol. 2012;86(12):6979–85. doi: 10.1128/JVI.00406-12. Epub 2012 Apr 11. PubMed PMID: 22496224; PubMed Central PMCID: PMC3393572.Google Scholar

Petersdorf, EW, Gooley, TA, Malkki, M, Bacigalupo, AP, Cesbron, A, Du Toit, E et al; International Histocompatibility Working Group in Hematopoietic Cell Transplantation. HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation. Blood. 2014;124(26):3996–4003. doi:10.1182/blood-2014-09-599969. Epub 2014 Oct 16.Google Scholar

Petersdorf, EW, Malkki, M, O’hUigin, C, Carrington, M, Gooley, T, Haagenson, MD et al. High HLA-DP expression and graft-versus-host disease. N Engl J Med. 2015;373(7):599–609. doi:10.1056/NEJMoa1500140. PubMed PMID: 26267621.CrossRefGoogle ScholarPubMed

Fernández-Viña, MA, Klein, JP, Haagenson, M, Spellman, SR, Anasetti, C, Noreen, H et al. Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. Blood. 2013;121(22):4603–10. doi: 10.1182/blood-2013-02-481945. Epub 2013 Apr 17.Google Scholar

Oudshoorn, M, Doxiadis, II, van den Berg-Loonen, PM, Voorter, CE, Verduyn, W, Claas, FH. Functional versus structural matching: can the CTLp test be replaced by HLA allele typing? Hum Immunol. 2002;63(3):176–84.Google Scholar

Fernandez-Viña, MA, Wang, T, Lee, SJ, Haagenson, M, Aljurf, M, Askar, M et al. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood. 2014;123(8):1270–8. doi:10.1182/blood-2013-10-532671. Epub 2014 Jan 9.Google Scholar

Zino, E, Frumento, G, Marktel, S, Sormani, MP, Ficara, F, Di Terlizzi, S et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood. 2004;103(4):1417–24. Epub 2003 Oct 23.Google Scholar

Fleischhauer, K, Shaw, BE, Gooley, T, Malkki, M, Bardy, P, Bignon, JD et al; International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol. 2012;13(4):366–74. doi:10.1016/S1470-2045(12)70004–9. Epub 2012 Feb 15. Erratum in: Lancet Oncol. 2012;13(4):e134-5.Google Scholar

Fuchs, EJ. HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide. Bone Marrow Transplant. 2015;50(Suppl 2):S31–6. doi: 10.1038/bmt.2015.92.Google Scholar

Bashey, A, Solomon, SR. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor. Bone Marrow Transplant. 2014;49(8):999–1008. doi: 10.1038/bmt.2014.62. Epub 2014 May 19 (Review).Google Scholar